Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 Vaccines in Hong Kong

medRxiv(2021)10.1101/2021.10.28.21265635Source: DataRank Database

Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 Vaccines in Hong Kong is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0.524. It has been cited 32 times.

N/A

0.524DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (25)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.524

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (19)

Carolyn A. Cohen ORCID,Samuel M. S. Cheng ORCID,Chunke Chen,Kin On Kwok ORCID,Karen Yiu

Live enrichment

PubMed:21097893 OpenAlex:https://openalex.org/W3215946639

National Institutes of Health

Grant: 5R01AI123926-02

Multi-platform High Throughput Screens for Filoviral Replication Inhibitors

National Institutes of Health

Grant: 4R01AI107056-04

STRUCTURAL BASIS FOR IMMUNE EVASION BY RSV NON-STRUCTURAL PROTEINS

National Institutes of Health

Grant: 5P01AI120943-03

Structural and Functional Characterization of the Ebola Virus Replication Complex

greenLicense: CC BY NC

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2021/10/30/2021.10.28.21265635.full.pdf

repositoryhttps://doi.org/10.1101/2021.10.28.21265635

https://doi.org/10.1111/resp.14191

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/resp.14191

Fields of Study

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesImmunotherapy and Immune Responses0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

MedicineImmunogenicityAntibodyVaccinationCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyImmunologyInternal medicineAdultCOVID-19 VaccinesSARS-CoV-2610COVID-19Leukocytes, MononuclearHong KongHumansORIGINAL ARTICLESBNT162 Vaccine

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being